Literature DB >> 7779094

Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells.

R Kokenyesi1, J E Silbert.   

Abstract

Recombinant domain I of mouse perlecan was expressed in Chinese hamster ovary (CHO K1) cells and affinity purified on Ni-agarose. Gel chromatography followed by characterization of glycosaminoglycans by the use of glycosaminoglycan lyases showed that the recombinant proteoglycans contained, on average, three glycosaminoglycan chains of heparan sulfate or chondroitin/dermatan sulfate of approximately 12 kDa median size. These data demonstrate that domain I has functional sites for attachment of glycosaminoglycans and indicate that the glycosaminoglycan chains of native perlecan are grouped at its N-terminal end. This, in turn, suggests that the likely function of domain I in perlecan would be to provide for the addition of glycosaminoglycan chains to the core protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779094     DOI: 10.1006/bbrc.1995.1805

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Cyclic AMP regulates basement membrane heparan sulfate proteoglycan, perlecan, metabolism in rat glomerular epithelial cells.

Authors:  C W Ko; B Bhandari; J Yee; W C Terhune; R Maldonado; B S Kasinath
Journal:  Mol Cell Biochem       Date:  1996-09-06       Impact factor: 3.396

2.  Comparative characterisation of recombinant invertebrate and vertebrate peptide O-Xylosyltransferases.

Authors:  Andrea Brunner; Daniel Kolarich; Josef Voglmeir; Katharina Paschinger; Iain B H Wilson
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

3.  Perlecan displays variable spatial and temporal immunolocalisation patterns in the articular and growth plate cartilages of the ovine stifle joint.

Authors:  James Melrose; Susan Smith; Martin Cake; Richard Read; John Whitelock
Journal:  Histochem Cell Biol       Date:  2005-06-17       Impact factor: 4.304

4.  Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA.

Authors:  D Aviezer; R V Iozzo; D M Noonan; A Yayon
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

5.  Epidermal transformation leads to increased perlecan synthesis with heparin-binding-growth-factor affinity.

Authors:  P Tapanadechopone; S Tumova; X Jiang; J R Couchman
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

6.  Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.

Authors:  Arivalagan Muthusamy; Carlton R Cooper; Ronald R Gomes
Journal:  BMC Biochem       Date:  2010-11-03       Impact factor: 4.059

Review 7.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

8.  Similarity of recombinant human perlecan domain 1 by alternative expression systems bioactive heterogenous recombinant human perlecan D1.

Authors:  April L Ellis; Wensheng Pan; Guang Yang; Kim Jones; Christine Chuang; John M Whitelock; Arthur A DeCarlo
Journal:  BMC Biotechnol       Date:  2010-09-09       Impact factor: 2.563

9.  A role for heparan sulfate proteoglycans in Plasmodium falciparum sporozoite invasion of anopheline mosquito salivary glands.

Authors:  Jennifer S Armistead; Iain B H Wilson; Toin H van Kuppevelt; Rhoel R Dinglasan
Journal:  Biochem J       Date:  2011-09-15       Impact factor: 3.766

10.  Versican is crucial for the initiation of cardiovascular lumen development in medaka (Oryzias latipes).

Authors:  Nishant Mittal; Sung Han Yoon; Hirokazu Enomoto; Miyama Hiroshi; Atsushi Shimizu; Atsushi Kawakami; Misato Fujita; Hideto Watanabe; Keiichi Fukuda; Shinji Makino
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.